Main Session
Sep 28
SS 12 - Small Cell Lung Cancer and Thymic Malignancies

155 - Post-Chemoradiotherapy Molecular Residual Disease (MRD) Clearance Determines Long-Term Survival in Limited-Stage Small Cell Lung Cancer: A Prospective Longitudinal Study

08:10am - 08:20am ET

Presenter(s)

Yaru Tian, - Shandong Cancer Hospital and Institute, Jinan,